Australia: A Key Focus for Oncobeta
With one of the highest incidences of skin cancer in the world found here in…
Browsing: Industry Spotlight
Celebrating 20 years of pioneering targeted prostate cancer treatment at Greenslopes Private Hospital
Original three-person clinical team continuing to offer LDR-brachytherapy to Queensland men in need Clinicians and patients…
Protected: A new treatment breakthrough for non-melanoma skin cancer
This content is password-protected. To view it, please enter the password below. Password:
Protected: 2022: A breakthrough year for OncoBeta’s Rhenium-SCT®
This content is password-protected. To view it, please enter the password below. Password:
Interim results from AUS-PREDICT registry show a significant change in radiation treatment recommendations when using DCISionRT test
DCISionRT is a novel molecular test that assesses the 10-year risk of recurrence after Breast…
How can we make integrative oncology care work in regional areas?
Integrative oncology can best be described as patient-centred, evidence-based comprehensive cancer care that includes conventional…
Improving head and neck radiotherapy in developing countries in real-time
How can we optimise head and neck cancer treatments in developing countries? Can it be…
Breakthrough in synthesising anti-cancer compound found in Atherton Tablelands
Stanford University researchers (USA) have discovered a rapid and sustainable way to synthetically produce a…
Protected: OncoBeta’s CEO and Managing Director Shannon D. Brown III talks about its innovative non-invasive skin cancer treatment Rhenium-SCT®
This content is password-protected. To view it, please enter the password below. Password:
Ribociclib offers more life in the first-line setting for postmenopausal HR+/HER2- advanced breast cancer patients
Novartis today announced updated median overall survival (OS) results for ribociclib in combination with fulvestrant…